Blood Cancer Discovery (BCD)

Blood Cancer Discovery publishes high-quality Research Articles and Briefs representing major advances in basic, translational, and clinical research of leukemia, lymphoma, myeloma, and associated diseases. The topics appropriate for coverage include but are not limited to the following: molecular and cellular features of pathogenesis, therapy response and relapse, transcriptional circuits, stem cells, differentiation, microenvironment, metabolism, immunity, mutagenesis, and clonal evolution. These subjects are characterized in animal disease models as well as in high-dimensional clinical data landscapes. The journal welcomes submissions on new pharmacological, biological, and living cell therapies; new diagnostic tools; prognostic, diagnostic, and pharmacodynamic biomarkers; and computational and machine learning approaches to personalized medicine, from preclinical proof of concept to clinical trials and real-world evidence. As a forum for diverse ideas shaping future research directions, the journal will publish Reviews, Perspectives, and Commentaries on topics of broad interest in hematooncology. Blood Cancer Discovery will provide a critical outlet for high-impact basic, translational, and clinical research on all disease subtypes of leukemia, lymphoma, myeloma, and associated diseases. Studies published in Blood Cancer Discovery will describe mechanisms underlying disease biology; diagnostic and therapeutic development; and translation of these data into clinical trials. Blood Cancer Discovery (BCD) (Print ISSN: 2643-3230; Online ISSN: 2643-3249) is published bimonthly, one volume/year, by the American Association for Cancer Research, Inc. (AACR).

Blood Cancer Discovery (BCD) is :-

• International, Peer-Reviewed, Open Access, Refereed, Hematology, Oncology, Molecular Biology, Immunology, Stem Cell Research, Translational Medicine , Online or Print , Bi-Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2643-3230, E-ISSN: 2643-3249, Established: 2020, Impact Factor: 11.5
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE